Ascorbic acid - McGuff Pharmaceuticals

Drug Profile

Ascorbic acid - McGuff Pharmaceuticals

Alternative Names: Ascor; Ascorbic acid injection - McGuff Pharmaceuticals; Vitamin C injection - McGuff Pharmaceuticals

Latest Information Update: 05 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator McGuff
  • Class Furans; Small molecules; Sugar acids; Vitamins
  • Mechanism of Action Ascorbic acid replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Vitamin C deficiency

Most Recent Events

  • 05 Oct 2017 Launched for Vitamin C deficiency in USA (IV)
  • 02 Oct 2017 Registered for Vitamin C deficiency in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top